International Excellence in Endocrinology Award Tasnim Ahsan, MRCP, FRCP, FCPS Ahsan is the professor emerita at the Jinnah Postgraduate Medical Centre and the founding dean of the Medicell Institute of Diabetes Endocrinology & Metabolism in Karachi, Pakistan. She is an internationally renowned clinician and educator who has contributed to the establishment and growth of the...
Sidney H. Ingbar Distinguished Service Award Beverly M.K. Biller, MD A professor of medicine at Harvard Medical School and a physician at Massachusetts General Hospital in Boston, Mass., Biller has been a dedicated and tireless leader of the Endocrine Society for more than a quarter century, deeply impacting the Society and the field of endocrinology....
Meet the 2023 Laureates: Myles Brown, MD, and Márta Korbonits, MD, PhD, DSc, FRCP
Gerald D. Aurbach Award for Outstanding Translational Research This annual award recognizes outstanding contributions to research that accelerates the transition of scientific discoveries into clinical applications. This year, the award has two worthy recipients, Myles Brown, MD; and Márta Korbonits, MD, PhD, DSc, FRCP. Myles Brown, MD Brown is the Emil Frei III Professor of...
Meet the 2023 Endocrine Society Laureates: Mitchell A. Lazar, MD, PhD
Fred Conrad Koch Lifetime Achievement Award Mitchell A. Lazar, MD, PhD Lazar is the Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and the founding director of the university’s Institute for Diabetes, Obesity, and Metabolism. He is an endocrinologist and...
New Endocrine Society Guideline Suggests Hypercalcemia of Malignancy Treatment Options
Protocols for treating this common cancer complication are provided in latest Clinical Practice Guideline Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society’s new Clinical Practice Guideline. The guideline, titled “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society...
Q&A: Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD
Endocrine News talks with Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating hypercalcemia of malignancy. Hypercalcemia of malignancy (HCM) is the most common metabolic complication of cancer, but its incidence may be declining due to...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
Q&A: Anthony L. McCall, MD, PhD, FACP, and David C. Lieb, MD, FACP
Endocrine News talks with Anthony L. McCall, MD, PhD, FACP and David C. Lieb, MD, FACP, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on managing hypoglycemia in people with diabetes. In the last decade or so, the amount of progress made in treating people with hypoglycemia has...
